In a move triggering widespread anxiety among healthcare professionals and researchers, the newly inaugurated US president announced yesterday that the country is withdrawing from the World Health Organization (WHO). This decision may radically alter the landscape of infection prevention and control (IPC) practices across the globe, particularly in the United States. The WHO has been instrumental in formulating IPC policies, mounting global responses to infectious diseases, and driving the accessibility to technical expertise and resources for many national health systems.
This conspicuous absence of the US from WHO could potentially pose significant threats to the nation’s preparedness and response to public health threats. In a press release, the WHO expressed its dissatisfaction with the recent development, fervently hoping for the US to reconsider. WHO underscores how both parties have benefited from this long-standing relationship since the organization’s early days in 1948.
Notably, eradication efforts against diseases like smallpox and polio have proven successful through joint collaboration. One of the most significant concerns regarding this withdrawal is the potential loss of IPC guidelines and recommendations, the update and provision of which has always been a strength of the WHO. The lack of access to such pivotal resources could lead to inconsistencies in IPC policies across US healthcare facilities, potentially compromising patient safety and the nation’s ability to combat healthcare-associated infections (HAIs).
The withdrawal could also present obstacles in information-sharing activities with other countries, slowing down the detection and response to global outbreaks. This delay could, in turn, impact the effectiveness of IPC interventions. The decision could have grave implications on healthcare workers, especially regarding the training and support they receive in infection control practices. WHO resources like training modules and educational programs are critical to ensure that frontline workers are effectively equipped to manage infections. Reduced WHO support could lead to deficits in education and preparedness.
Furthermore, the lack of WHO-approved personal protective equipment (PPE) standards could lead to disparities in the quality and availability of protective gear, putting healthcare workers at risk. The repercussions of this withdrawal ripple to the federal and state-level infection control efforts as well. The absence of WHO collaboration can adversely affect programs by agencies like the CDC, and render monitoring and tracking of infection rates challenging.
Further, the decision could lead to confusion in hospitals and public health agencies regarding the choice of alternative guidelines, leading to fragmentation in IPC policies. Considering WHO’s pivotal role in funding research and development for disease prevention and control, the US withdrawal could also affect access to international collaborations, especially in areas like antibiotic resistance and pandemic preparedness.
Less affluent nations, already grappling with barriers in advancing their IPC measures due to inadequate resources, are likely to bear the brunt of this move. In the absence of equitable funding, low-income countries face an uphill battle in adopting advanced diagnostic tools and technologies. With the US reducing overall funding and disrupting global balance, these vulnerable nations may face further challenges in combating infectious diseases.
The move has caused disquiet among healthcare workers, with reactions ranging from calling it ‘deeply troubling’ to ‘devastating’. The decision has been seen as a blow to the credibility of global health governance, potentially undermining public faith in WHO’s capacity to unite nations and tackle critical healthcare challenges. However, some see this as an opportunity for WHO to accelerate reforms and diversify its funding sources to minimize the risk of being collateral damage in political disputes.
As the situation unfolds, IPC practices in the US and globally may encounter significant challenges, making it imperative to maintain strong international collaborations and ensure healthcare workers have access to effective IPC practices.